Opioid use disorder and COVID-19: Implications for policy and practice
Opioid use disorder and COVID-19: Implications for policy and practice
复制标题
DOI：
10.1097/01.jaa.0000742976.14811.36
复制
发表时间：
2021-06-01
影响因子：
1.1
通讯作者：
Evans, Matthew
中科院分区：
文献类型：
--
作者：
Mitchell, Michaela;Shee, Kameron;Evans, Matthew
初步数据表明，在 COVID-19 之后，与阿片类药物相关的过量死亡有所增加。尽管国家支持扩大医师助理 (PA) 和 NP 在为阿片类药物使用障碍患者提供服务方面的作用，但这些临床医生仍面临复杂而严格的监管障碍。 COVID-19 引发了监管机构和联邦机构的重大变化，但医生、PA 和 NP 之间仍然存在不同的政策和法规。 COVID-19 和阿片类药物使用障碍的双重流行凸显了支持患者、社区和临床医生所需的基础设施不足，并可能成为消除护理障碍的催化剂。
Preliminary data suggest that opioid-related overdose deaths have increased subsequent to COVID-19. Despite national support for expanding the role of physician assistants (PAs) and NPs in serving patients with opioid use disorder, these clinicians are held to complex and stringent regulatory barriers. COVID-19 triggered significant changes from regulatory and federal agencies, yet disparate policies and regulations persist between physicians and PAs and NPs. The dual epidemics of COVID-19 and opioid use disorder highlight the inadequate infrastructure required to support patients, communities, and clinicians, and may serve as the catalyst for eliminating barriers to care.